The Use of Roxifiban (DMP754), a Novel Oral Platelet Glycoprotein IIb/IIIa Receptor Inhibitor, in Patients with Stable Coronary Artery Disease-Reference-Cited by-同舟云学术

The Use of Roxifiban (DMP754), a Novel Oral Platelet Glycoprotein IIb/IIIa Receptor Inhibitor, in Patients with Stable Coronary Artery Disease

Published:2003 Issue:2 Volume:3 Page:101-112
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:American Journal of Cardiovascular Drugs

Author:

Murphy Joseph,Wright R Scott,Gussak Ihor,Williams Brent,Daly Robert N,Cain Valerie A,Pieniaszek Henry J,Sy Sherwin K B,Ebling William,Simonson Kristen,Wilcox Racehl A,Kopecky Stephen L

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Reference25 articles.

1. Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

2. Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

3. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

4. Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels

5. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy and Safety of Antiplatelet Therapy in Patients With Acute Coronary Syndrome: A Scoping Review;Cureus;2023-11-29

2. Synthesis of 5-Vinyl-2-isoxazolines by Palladium-Catalyzed Intramolecular O-Allylation of Ketoximes;Organic Letters;2021-07-29

3. Enantio- and Chemoselective Intramolecular Iridium-Catalyzed O-Allylation of Oximes;Organic Letters;2021-03-22

4. Monofluorinated 5-membered rings via fluoromethylene transfer: synthesis of monofluorinated isoxazoline N-oxides;Organic & Biomolecular Chemistry;2021

5. Progress in the development of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic;Pharmacology & Therapeutics;2019-11